<div id="readability-page-1"><div> By Katherine Hamilton <pre></pre> Senseonics shares slid after the company announced the pricing of its planned underwritten public offering. Shares fell 24% to $5.04 on Friday, at one point touching a 52-week low of $4.96. The stock has lost 9% of its value this year. The maker of implantable glucose trackers said late Thursday night it would price its underwritten public offering of 8 million shares at $5 apiece. It is also offering 8 million pre-funded warrants for just under $5 apiece. Senseonics expects proceeds to be $80 million. It has granted underwriters a 30-day option to buy up to an additional 2.4 million shares at the public offering price, less underwriting discounts and commissions. The offering is set to close May 4. <pre></pre> Write to Katherine Hamilton at katherine.hamilton@wsj.com <pre></pre> (END) Dow Jones Newswires May 01, 2026 14:37 ET (18:37 GMT)Copyright (c) 2026 Dow Jones &amp; Company, Inc.</div></div>

Senseonics控股

納斯達克生物科技指數 ETF - iShares Nasdaq

標普生物技術 ETF - SPDR

醫藥突破 ETF - ALPS

標普生物技術 3 倍做多 - Direxion

生物科技 ETF - VanEck Vectors

紐交所高增長板生物技術指數 ETF - First Trust

動態生物技術與基因組 ETF - Invesco

Senseonics 的股價在宣佈以每股 5 美元的價格進行承銷公開發行後下跌了 24%，至 5.04 美元。該公司計劃發行 800 萬股股票和 800 萬份預先融資的認股權證，預計籌集 8000 萬美元。今年以來，該股已損失 9% 的價值，創下 52 周低點 4.96 美元。此次發行預計將於 5 月 4 日結束，承銷商獲得了 30 天的選擇權，可以額外購買 240 萬股

Senseonic Shares Slide on Underwritten Offering Price

MorningStar

Senseonic 的股票因包銷發行價格下跌